Sugi Predict

Sugi Predict / Compounds / SCHEMBL2228992

SCHEMBL2228992

SCHEMBL2228992

COC(=O)c1ccc(S(C)(=O)=O)cc1

nearest known ligand 0.69

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CA1 P00915 4/20 0.62
▸ CA2 P00918 4/20 0.62
▸ CA12 O43570 3/20 0.62
▸ CA9 Q16790 3/20 0.62
▸ CA14 Q9ULX7 3/20 0.62
▸ PTGS2 P35354 1/20 0.60
▸ FBP1 P09467 1/20 0.59
▸ TDP1 Q9NUW8 1/20 0.57
▸ POLB P06746 1/20 0.57
▸ CA7 P43166 1/20 0.57
▸ GLA P06280 2/20 0.56
▸ KDM4E B2RXH2 1/20 0.55
▸ NPC1 O15118 1/20 0.55
▸ ALDH1A1 P00352 1/20 0.55
▸ RAB9A P51151 1/20 0.55
▸ STS P08842 1/20 0.55
▸ TSHR P16473 1/20 0.54
▸ HPGD P15428 1/20 0.53
▸ VCAM1 P19320 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20262094 0.94 CA1 (0.72) CA1CA2CA12CA9CA14
SCHEMBL1832364 0.87 MAPT (0.72) TDP1POLBKDM4EALDH1A1TSHR
SCHEMBL29182540 0.85 PTGS2 (0.49) CA1CA2CA12CA9CA14
SCHEMBL9028776 0.85 CA12 (0.52) CA1CA2CA12CA9CA14
SCHEMBL7625358 0.85 CA12 (0.52) CA1CA2CA12CA9CA14
SCHEMBL4649735 0.85 PTGS2 (0.49) CA1CA2CA12CA9CA14
SCHEMBL11576291 0.85 ENPP2 (0.52) PTGS2
SCHEMBL68518 0.85 POLB (0.74) CA1CA2CA12CA9CA14
SCHEMBL25216009 0.84 CA1 (0.59) CA1CA2CA12CA9CA14
SCHEMBL5322110 0.83 CA1 (0.62) CA1CA2CA12CA9CA14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118666721-A Synthesis method of mesotrione 台州市博联贵金属有限公司 2024-09-20 — — CN claimed
CN-115232039-A Preparation method of 3-methyl-2-chloro-4-methylsulfonyl methyl benzoate 启农生物科技(北京)有限公司 2022-10-25 — — CN claimed
CN-118666721-A Synthesis method of mesotrione 台州市博联贵金属有限公司 2024-09-20 — — CN disclosed
CN-117276664-A High-voltage lithium ion battery electrolyte and lithium ion battery 合肥国轩高科动力能源有限公司 2023-12-22 — — CN disclosed
CN-116178225-A Method for synthesizing thioether compound by sulfoxide reduction 湖北滋兰生物医药科技有限公司 2023-05-30 — — CN disclosed
WO-2023073115-A1 PROTEIN AGGREGATION INHIBITING COMPOUNDS FOR PLANT DISEASE CONTROL MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2023-05-04 — — WO disclosed
EP-4173485-A1 PROTEIN AGGREGATION INHIBITING COMPOUNDS FOR PLANT DISEASE CONTROL Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2023-05-03 — — EP disclosed
CN-116003309-A Hydrazide compound, preparation method and application thereof 深圳微芯生物科技股份有限公司 2023-04-25 — — CN disclosed
US-20230041563-A1 N-(1,3,4-OXADIAZOL-2-YL)ARYLCARBOXAMIDES OR SALTS THEREOF, PREPARATION METHODS, HERBICIDAL COMPOSITIONS AND USES THEREOF QINGDAO KINGAGROOT CHEMICAL COMPOUND CO., LTD. (CN) 2023-02-09 — — US disclosed
US-10759765-B2 Heterocyclic carboxylic acid amide ligand and applications thereof in copper catalyzed coupling reaction of aryl halogeno substitute CE PHARM CO., LTD. (CN) 2020-09-01 — — US disclosed
CN-106715413-B piperazine derivatives as liver X receptor modulators VITAE PHARMACEUTICALS, INC. (US) 2019-11-01 — — CN disclosed
EP-1944305-A1 Quinoline derivatives as phosphodiesterase inhibitors GLAXO GROUP LIMITED (GB) 2008-07-16 — — EP disclosed
CN-1332944-C Amino acid accelerated CuI catalyzed aryl halide and coupling reaction of alkyl sulfonate SHANGHAI INST ORGANIC CHEM (CN) 2007-08-22 — — CN disclosed
US-20070142373-A1 Quinoline derivatives as phosphodiesterase inhibitors GLAXO GROUP LIMITED (GB) 2007-06-21 — — US disclosed
US-20070142373-A1 Quinoline derivatives as phosphodiesterase inhibitors GLAXO GROUP LIMITED (GB) 2007-06-21 — — US disclosed
US-20070049570-A1 Quinoline derivatives as phosphodiesterase inhibitors DEAN ANTHONY W 2007-03-01 — — US disclosed
US-20070049570-A1 Quinoline derivatives as phosphodiesterase inhibitors DEAN ANTHONY W 2007-03-01 — — US disclosed
CN-1651408-A Amino acid accelerated CuI catalyzed aryl halide and coupling reaction of alkyl sulfonate SHANGHAI INST ORGANIC CHEM (CN) 2005-08-10 — — CN disclosed
US-4610957-A SILVER HALIDE EMULSIONS, ACID AND BASE PRECUSORS FUJI PHOTO FILM CO., LTD. (JP) 1986-09-09 — — US disclosed
US-4327036-A FOR AROMATIC NUCLEUS E. I. DU PONT DE NEMOURS AND COMPANY (US) 1982-04-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230041563-A1 N-(1,3,4-OXADIAZOL-2-YL)ARYLCARBOXAMIDES OR SALTS THEREOF, PREPARATION METHODS, HERBICIDAL COMPOSITIONS AND USES THEREOF CYP2B6, CBR3, CYP2A6 CA1 1395/4885CA2 390/4885CA12 2019/4885
US-10759765-B2 Heterocyclic carboxylic acid amide ligand and applications thereof in copper catalyzed coupling reaction of aryl halogeno substitute AOC1, AOC2, AOC3 CA1 498/4885CA2 743/4885CA12 470/4885
US-20070049570-A1 Quinoline derivatives as phosphodiesterase inhibitors PDE3B, PDE4B, PDE4A CA1 4500/4885CA2 1594/4885CA12 4618/4885
US-20070142373-A1 Quinoline derivatives as phosphodiesterase inhibitors PDE3B, PDE4B, PDE4A CA1 4500/4885CA2 1594/4885CA12 4618/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.